New treatment for disfiguring skin condition

by Claire Mooney
Researchers see the light over new treatment

Researchers from The University of Manchester and Salford Royal NHS Foundation Trust have tested a new way to treat a disfiguring skin condition.

Telangiectatases are knot-like clusters of blood vessels on the skin which can occur in 30 to 50 per cent of with systemic sclerosis, a potentially serious and incurable auto-immune condition that affects .

Telangiectases tend to occur on the face, neck and upper limbs and can cause psychological issues for patients.

Currently, doctors use to blast the telangiectases and destroy them but this treatment can be painful at the time and result in bruising afterwards so researchers have been looking for an alternative.

Salford Royal is one of only a handful of Trusts in the UK specialising in systemic sclerosis, also known as scleroderma, and Consultant Rheumatologist Ariane Herrick, also Professor of Rheumatology at The University of Manchester's Institute for Inflammation and Repair, is a leading UK expert in the condition.

As part of the Trust's and University's wide range of studies to improve care of scleroderma patients, researchers tested using intense pulsed light (IPL) instead of laser treatment. IPL is often used cosmetically for treating birthmarks and for hair removal.

Their pilot study treated 19 patients with telangiectases, using IPL on one side of the face and laser treatment on the other. They had three treatments over the course of eight weeks before the results were analysed using close-up photographs and specialist imaging.

The research showed that the effects were roughly comparable but IPL had fewer side effects.

Salford Royal Rheumatology researcher Dr Graham Dinsdale, who is also a Research Associate at the University's Institute of Inflammation and Repair, said: "While this was only a small-scale , it does suggest the potential for an alternative, less painful, treatment for telangiectases. We will continue to do all we can to find new and better treatments for patients with , which is a very serious and debilitating condition."

add to favorites email to friend print save as pdf

Related Stories

New study to develop personalised treatments for psoriasis

Nov 06, 2013

A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's ...

Recommended for you

US warns Ebola could infect 1.4 million by 2015

2 hours ago

The number of Ebola infections in Liberia and Sierra Leone could skyrocket to 1.4 million by January 2015, according to a worst-case scenario released by US health authorities Tuesday.

Team finds method for more precise diagnosis of pneumonia

2 hours ago

A patient survives life-threatening trauma, is intubated in the intensive care unit (ICU) to support his or her affected vital functions, starts to recover, and then develops pneumonia. It's a scenario well-known to physicians, ...

Screen women for chlamydia, gonorrhea, experts say

4 hours ago

(HealthDay)—All sexually active women should be screened for two of the most common sexually transmitted infections: chlamydia and gonorrhea, according to new recommendations from the U.S. Preventive Services ...

Noninvasive devices may help migraines, FDA says

4 hours ago

(HealthDay)—Two new prescription devices approved by the U.S. Food and Drug Administration (FDA) may provide some relief for people with migraine headaches who don't tolerate migraine medications well, ...

User comments